We demonstrate that peritoneal macrophages (PMs) are abundant in ascitic fluid of patients with liver cirrhosis and are susceptible to HIV-1 infection. PMs expressed CD68, a differentiation marker, exhibited phagocytic activity, and survived in culture for 2 months without additional growth factors.... | PMID: 20065862

PDF is available here.

Heterocyclic amidine derivatives have been synthesized by condensation of 2-cyanopyrazine, 4-cyanopyridine and 2-cyanopyridine with furfurylamine, histamine, 1-(3-aminopropyl)imidazole, 4-picolylamine, 2-picolylamine, and tryptamine respectively, in the presence of sodium methoxide as well as via mi... | PMID: 19959259

PDF is available here.

Small bowel wall enhancement was significantly higher (p<0.05) in inflamed compared to normal segments at 20-40s (SNR inflamed: 58.7+/-33.8 vs normal: 36.0+/-19.8; p=0.048; CNR inflamed: 34.8+/-23.4 vs normal: 16.3+/-11.2; p=0.017) and at 60-80s (SNR: 60.3+/-25.1 vs 41.9+/-20.0; p=0.049; CNR: 34.9+/... | PMID: 19131201

PDF is available here.

Hepatic fibrosis occurs in response to several aggressive agents and is a predisposing factor in cirrhosis. Hepatotrophic factors were shown to stimulate liver growth and to restore the histological architecture of the liver. They also cause an improvement in liver function and accelerate the revers... | PMID: 20520980

PDF is available here.

These results suggest a role for CXCL12/CXCR4 signaling in both normal micturition and with bladder hyperreflexia following bladder inflammation.... | PMID: 20032115

PDF is available here.

The cellular and molecular events that initiate and promote malignant glioma development are not completely understood. The treatment modalities designed to promote its demise are all ultimately ineffective, leading to disease progression. In this issue of the JCI, Kioi et al. demons... | PMID: 20179347

PDF is available here.

The first chemoselective direct dehydrative cross-coupling of tautomerizable heterocycles with alkynes has been achieved via C-H/C-OH bond activations with direct C(sp(2))-C(sp) bond formation, which is in line with ideal synthesis using readily available materials. | PMID: 20449299

PDF is available here.

PMID: 20052706

PDF is available here.

PMID: 20157917

PDF is available here.

PMID: 20143373

PDF is available here.

PMID: 20083979

PDF is available here.

We measured concentrations of tulathromycin (TM) in plasma, ELF and BAC in 21 warm-blooded foals 24 and 192 h after first and last intramuscular injection of 2.5 mg/kg TM once weekly for 6 weeks. In 11 foals, TM was combined with RIF (10 mg/kg twice daily), and mRNA expression of ABCB1 and ABCC2 in... | PMID: 20012942

PDF is available here.

The design and synthesis of a new class of p38alpha MAP kinase inhibitors based on 4-fluorobenzylpiperidine heterocyclic oxalyl amides are described. Many of these compounds showed low-nanomolar activities in p38alpha enzymatic and cell-based cytokine TNFalpha production inhibition assays. The optim... | PMID: 20031411

PDF is available here.

We have termed as "BioCores." This article explains how the BioCores can be used for the design of novel lead-like scaffolds.... | PMID: 19468851

PDF is available here.

We have termed as "BioCores." This article explains how the BioCores can be used for the design of novel lead-like scaffolds.... | PMID: 19468851

PDF is available here.

We have termed as "BioCores." This article explains how the BioCores can be used for the design of novel lead-like scaffolds.... | PMID: 19468851

PDF is available here.

The effects of several ionic liquids (ILs) as mobile-phase additives in HPLC with fluorescence and UV-Vis detection for the determination of six heterocyclic aromatic amines were evaluated using two different C(18) stationary phases with moderate silanol activity. The studied ILs wer... | PMID: 20087869

PDF is available here.

The effects of several ionic liquids (ILs) as mobile-phase additives in HPLC with fluorescence and UV-Vis detection for the determination of six heterocyclic aromatic amines were evaluated using two different C(18) stationary phases with moderate silanol activity. The studied ILs wer... | PMID: 20087869

PDF is available here.

A series of new modifications of alkyl cationic glycerolipids with hetero polar domain has been synthesized. The most active compound rac-N-(4-[(2-ethoxy-3-octadecyloxy)prop-1-yloxycarbonyl]butyl)-N'-etylimidazoliyiodid in micromolar concentrations causes a delay of cell cycle in phase G1, DNA fragm... | PMID: 20823928

PDF is available here.

We report the case of a 26-year-old man with testicular cancer who was extensively pretreated and failed to mobilize a sufficient number of HPSCs after cytotoxic chemotherapy and the administration of G-CSF and pegylated G-CSF (PEG-G-CSF). Using a combination of plerixafor, G-CSF and PEG-G-GSF after... | PMID: 21099212

PDF is available here.

We examined the efficacy of post transplant administration of a specific CXCR4 antagonist (AMD3100) in improving animal survival and in enhancing donor hematopoietic cell engraftment using a congeneic mouse transplantation model. AMD3100 was administered subcutaneously at 5 mg/kg body weight 3 times... | PMID: 20596257

PDF is available here.

Coking wastewater is one of the most toxic industrial effluents since it contains high concentrations of ammonia and toxic organic compounds. Nitrification might be upset by the inhibitory effect of organic compounds during the biological treatment of the wastewater. In this study, shortcut nitrific... | PMID: 21045337

PDF is available here.

Plerixafor, a novel CXCR4 inhibitor, is effective in mobilizing PBSCs particularly when used in conjunction with G-CSF. In four cohorts, this pilot study explored the safety of plerixafor mobilization when incorporated into a conventional stem cell mobilization regimen of chemotherapy and G-CSF. For... | PMID: 19483760

PDF is available here.

Pharmacological manipulation of CXCR4 has proven clinically useful for mobilization of stem and progenitor cells and in several preclinical models of disease. It is a key component in the localization of leukocytes and stem cells. For patients with multiple myeloma and non-Hodgkin's Lymphoma, treatm... | PMID: 20397073

PDF is available here.